Matthew Rosini, JD
Chief Financial and Administrative Officer
Matthew Rosini is co-CEO and Chief Financial and Administrative Officer of Tern Therapeutics, overseeing financial, legal, HR and other administrative functions. Prior to cofounding Tern, Mr. Rosini was Head of Strategic Initiatives at REGENXBIO Inc., where he advised the executive team with regard to corporate strategy and strategic transactions, and was a Partner at FoxKiser LLP, where he provided strategic consulting and legal advice to life sciences clients. Mr. Rosini also spent nearly 20 years in private practice and as in-house counsel representing privately-held and publicly-traded companies through their entire life cycles, as well as representing private equity and venture capital investors. Mr. Rosini received a J.D. from Boston College Law School and a B.S. in Finance from Boston College.
123-456-7890